{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T05:13:26Z","timestamp":1771737206697,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,12]],"date-time":"2011-02-12T00:00:00Z","timestamp":1297468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10549-011-1369-6","type":"journal-article","created":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T11:18:08Z","timestamp":1297423088000},"page":"811-815","source":"Crossref","is-referenced-by-count":17,"title":["Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis"],"prefix":"10.1007","volume":"128","author":[{"given":"Wei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Feng","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,12]]},"reference":[{"key":"1369_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"1369_CR2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc1476","volume":"4","author":"PD Pharoah","year":"2004","unstructured":"Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4:850\u2013860","journal-title":"Nat Rev Cancer"},{"key":"1369_CR3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10549-010-0858-3","volume":"124","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Zhang J, Zhu XD, Zheng CL, Sun S, Wang ZH (2010) The p21 Ser31Arg polymorphism and breast cancer risk: a meta-analysis involving 51, 236 subjects. Breast Cancer Res Treat 124:475\u2013479","journal-title":"Breast Cancer Res Treat"},{"key":"1369_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-010-0813-3","volume":"124","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K (2010) XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28, 709 subjects. Breast Cancer Res Treat 124:229\u2013235","journal-title":"Breast Cancer Res Treat"},{"key":"1369_CR5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10549-010-0781-7","volume":"123","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K (2010) TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47, 817 subjects. Breast Cancer Res Treat 123:563\u2013567","journal-title":"Breast Cancer Res Treat"},{"key":"1369_CR6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-010-0767-5","volume":"123","author":"LX Qiu","year":"2010","unstructured":"Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B (2010) BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44, 903 subjects. Breast Cancer Res Treat 123:487\u2013490","journal-title":"Breast Cancer Res Treat"},{"key":"1369_CR7","doi-asserted-by":"crossref","first-page":"18665","DOI":"10.1074\/jbc.M100855200","volume":"276","author":"M Araki","year":"2001","unstructured":"Araki M, Masutani C, Takemura M (2001) Centrosome protein centrin 2\/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J Biol Chem 276:18665\u201318672","journal-title":"J Biol Chem"},{"key":"1369_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1568-7864(01)00008-8","volume":"1","author":"K Sugasawa","year":"2002","unstructured":"Sugasawa K, Shimizu Y, Iwai S, Hanaoka F (2002) A molecular mechanism for DNA damage recognition by the xeroderma pigmentosum group C protein complex. DNA Repair 1:95\u2013107","journal-title":"DNA Repair"},{"key":"1369_CR9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/carcin\/21.10.1821","volume":"21","author":"SG Khan","year":"2000","unstructured":"Khan SG, Metter EJ, Tarone RE (2000) A new xeroderma pigmentosum group C poly(AT) insertion\/deletion polymorphism. Carcinogenesis 21:1821\u20131825","journal-title":"Carcinogenesis"},{"key":"1369_CR10","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/carcin\/bgn193","volume":"29","author":"TR Smith","year":"2008","unstructured":"Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29:2132\u20132138","journal-title":"Carcinogenesis"},{"key":"1369_CR11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejca.2007.10.027","volume":"44","author":"J Shen","year":"2008","unstructured":"Shen J, Gammon MD, Terry MB, Teitelbaum SL, Eng SM, Neugut AI (2008) Xeroderma pigmentosum complementation group C genotypes\/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Eur J Cancer 44:710\u2013717","journal-title":"Eur J Cancer"},{"key":"1369_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-006-9263-3","volume":"101","author":"TJ Jorgensen","year":"2007","unstructured":"Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ (2007) Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 101:65\u201371","journal-title":"Breast Cancer Res Treat"},{"key":"1369_CR13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/carcin\/bgi330","volume":"27","author":"LE Mechanic","year":"2006","unstructured":"Mechanic LE, Millikan RC, Player J (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27:1377\u20131385","journal-title":"Carcinogenesis"},{"key":"1369_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cccn.2005.03.047","volume":"359","author":"L Zhang","year":"2005","unstructured":"Zhang L, Zhang Z, Yan W (2005) Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359:150\u2013155","journal-title":"Clin Chim Acta"},{"key":"1369_CR15","first-page":"917","volume":"11","author":"A Forsti","year":"2004","unstructured":"Forsti A, Angelini S, Festa F (2004) Single nucleotide polymorphisms in breast cancer. Oncol Rep 11:917\u2013922","journal-title":"Oncol Rep"},{"key":"1369_CR16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/1055-9965.EPI-06-0218","volume":"15","author":"J Shen","year":"2006","unstructured":"Shen J, Desai M, Agrawal M (2006) Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 15:1614\u20131619","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1369_CR17","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/ijc.23361","volume":"122","author":"RE Shore","year":"2008","unstructured":"Shore RE, Zeleniuch-Jacquotte A, Currie D, Mohrenweiser H, Afanasyeva Y, Koenig KL (2008) Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer 122:2101\u20132105","journal-title":"Int J Cancer"},{"key":"1369_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101\u2013129","journal-title":"Biometrics"},{"key":"1369_CR19","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"1369_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"1369_CR21","first-page":"15","volume":"8","author":"A Tobias","year":"1999","unstructured":"Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15\u201317","journal-title":"Stata Tech Bull"},{"key":"1369_CR22","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1369_CR23","first-page":"14","volume":"5","author":"SJ Taylor","year":"1998","unstructured":"Taylor SJ, Tweedie RI (1998) Practical estimates of the effect of publication bias in meta- analysis. Australas Epidemiologist 5:14\u201317","journal-title":"Australas Epidemiologist"},{"key":"1369_CR24","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/nar\/gkf469","volume":"30","author":"SG Khan","year":"2002","unstructured":"Khan SG, Muniz-Medina V, Shahlavi T (2002) The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 30:3624\u20133631","journal-title":"Nucleic Acids Res"},{"key":"1369_CR25","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1158\/1055-9965.1788.13.11","volume":"13","author":"MS Marin","year":"2004","unstructured":"Marin MS, Lopez-Cima MF, Garcia-Castro L, Pascual T, Marron MG, Tardon A (2004) Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 13:1788\u20131793","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1369_CR26","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/sj.bjc.6602616","volume":"92","author":"SC Sak","year":"2005","unstructured":"Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE (2005) The polyAT, intronic IVSII-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 92:2262\u20132265","journal-title":"Br J Cancer"},{"key":"1369_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/carcin\/23.2.295","volume":"23","author":"Y Qiao","year":"2002","unstructured":"Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M (2002) Modulation of repair of ultraviolet damage damage in the host-cell reactivation assay by polymorphic XPC and XPD\/ERCC2 genotypes. Carcinogenesis 23:295\u2013299","journal-title":"Carcinogenesis"},{"key":"1369_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","volume":"4","author":"JN Hirschhorn","year":"2002","unstructured":"Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45\u201361","journal-title":"Genet Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1369-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-011-1369-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-011-1369-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:01:33Z","timestamp":1685944893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-011-1369-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,12]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1369"],"URL":"https:\/\/doi.org\/10.1007\/s10549-011-1369-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,12]]}}}